Paclitaxel nanoparticles for the potential treatment of brain tumors

Journal of Controlled Release

Volumn 99, Issue 2, 2004, Pages 259-269

  Koziara, Joanna M ^a   Lockman, Paul R ^b   Allen, David D ^b   Mumper, Russell J ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

^b TEXAS TECH UNIVERSITY   (United States)

Author keywords

Blood brain barrier; Brain metastases; Brain perfusion; Brain uptake; P glycoprotein

Indexed keywords

BRAIN METASTATES; BRAIN TUMORS; CYTOTOXIC AGENTS; EFFLUX TRANSPORTER;

ALCOHOLS; BLOOD; CELLS; CHEMOTHERAPY; DISEASES; DRUG INFUSION; DRUG INTERACTIONS; SORPTION; TUMORS;

BRAIN;

CREMOPHOR; GLYCOPROTEIN; GLYCOPROTEIN P; HEXADECANOL; NANOPARTICLE; PACLITAXEL; POLYSORBATE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD BRAIN BARRIER; BRAIN PERFUSION; BRAIN TUMOR; CONTROLLED STUDY; CYTOTOXICITY; DRUG BINDING; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG RELEASE; DRUG STABILITY; DRUG UPTAKE; HUMAN; HUMAN CELL; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; STATISTICAL SIGNIFICANCE; TOXICITY; TUMOR CELL;

ADJUVANTS, PHARMACEUTIC; ANIMALS; ANTINEOPLASTIC AGENTS; BRAIN NEOPLASMS; CELL LINE, TUMOR; CELL SURVIVAL; CHEMISTRY, PHARMACEUTICAL; FATTY ALCOHOLS; GLYCEROL; HUMANS; INHIBITORY CONCENTRATION 50; MALE; NANOSTRUCTURES; PACLITAXEL; POLYETHYLENE GLYCOLS; POLYSORBATES; RATS; RATS, INBRED F344; TECHNOLOGY, PHARMACEUTICAL; TRITIUM; VEHICLES;

EID: 4544240398     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jconrel.2004.07.006     Document Type: Article

References (39)

1. R. Panchagnula Pharmaceutical aspects of Paclitaxel Int. J. Pharm. 172 1998 1 15
2. E.K. Rowinsky On pushing the outer edge of the outer edge of paclitaxel's dosing envelope Clin. Cancer Res. 5 1999 481 486
3. K.W. Li, W. Dang, B.M. Tyler, G. Troiano, T. Thian, H. Brem, and K.A. Walter Polilactofate microspheres for Paclitaxel delivery to central nervous system malignancies Clin. Anticancer Res. 15 9 2003 3441 3447
4. S. Fellner, B. Bauer, D.S. Miller, M. Schaffrik, M. Fankhänel, T. Spruß, G. Bernhardt, C. Graeff, L. Färber, H. Gschaidmeier, A. Buschsuer, and G. Fricker Transport of Paclitaxel (Taxol) across the blood-brain barrier in vitro and in vivo J. Clin. Invest. 10 9 2002 1309 1317
5. J.M. Gallo, S. Li, P. Guo, K. Reed, and J. Ma The effect of P-glycoprotein on Paclitaxel brain and brain tumor distribution in mice Cancer Res. 63 2003 5114 5117
6. A. Sparreboom, O.V. Tellingen, W.J. Nooijen, and J.H. Beijnen Tissue distribution, metabolism, and excretion of paclitaxel in mice Anticancer Drugs 7 1996 78 86
7. J.J. Heimans, J.B. Vermorken, J.G. Wolbers, C.M. Eeltink, O.W. Meijer, M.J. Taphoorn, and J.H. Beijnen Paclitaxel (Taxol) concentrations in brain tumor tissue Ann. Oncol. 5 10 1994 951 953
8. E.M. Kemper, A.E. van Zandbergen, C. Cleypool, H.A. Mos, W. Boogerd, J.H. Beijnen, and O. van Tellingen Increased penetration of Paclitaxel into the brain by inhibition of P-glycoprotein Clin. Cancer Res. 9 2003 2849 2855
9. A. Rice, M.L. Michaelis, G. Georg, Y. Liu, B. Turunen, and K.L. Audus Overcoming the blood-brain barrier to taxene delivery for neurodegenerative diseases and brain tumors J. Mol. Neurosci. 20 3 2003 339 343
10. N. Drion, M. Leimaire, J.M. Lefauconnier, and J.M. Scherrmann Role of p-glycoprotein in the blood-brain transport of colchicine and vinblastine J. Neurochem. 67 1996 1688 1693
11. A.H. Schinkel, E. Wagenaar, L. van Deemter, C.A. Mal, and P. Borst Absence of the mdr 1a p-glycoprotein in mice affects tissue distribution and pharmacokinetics of dexamethasone, digoxin, and cyclosporine Am. J. Clin. Invest. 96 1995 1698 1705
12. K. Singla, A. Garg, and D. Aggarwal Paclitaxel and its formulations Int. J. Pharm. 235 2002 179 192
13. N.K. Ibrahim, N. Desai, S. Legha, P. Soon-Shiong, R.L. Theriault, E. Rivera, B. Esmaeli, S.E. Ring, A. Bedikian, G.N. Hortobagyi, and J.A. Ellerhorst Phase I and pharmacokinetic study of ABI-007, a Cremophor-free, protein-stabilized, nanoparticle formulation of paclitaxel Clin. Cancer Res. 8 2002 1038 1044
14. B. Damascelli, G. Cantu, F. Mattavelli, P. Tamplenizza, P. Bidoli, E. Leo, F. Dosio, A. Cerrotta, G. Di Tolla, L. Frigerio, F. Garbagnati, R. Lanocita, A. Marchiano, G. Patelli, C. Spreafico, V. Ticha, V. Vespro, and F. Zunino Intraaterial chemotherapy with polyoxyethylated castor oil free paclitaxel, incorporated in albumin nanoparticles (ABI-007) Cancer 92 2001 2592 2602
15. L. Milas, K.A. Mason, N. Hunter, C. Li, and S. Wallace Poly(l-glutamic acid)-paclitaxel conjugate is a potent enhancer of tumor radiocurability Int. J. Radiat. Oncol. Biol. Phys. 55 2003 707 712
16. C. Li, R.A. Newman, Q.P. Wu, S. Ke, W. Chen, T. Hutto, Z. Kan, M.D. Brannan, C. Charnsangavej, and S. Wallace Biodistribution of paclitaxel and poly(l-glutamic acid)-paclitaxel conjugate in mice with ovarian OCa-1 tumor Cancer Chemother. Pharmacol. 46 2000 416 422
17. P.R. Lockman, J. Koziara, K.E. Roder, J. Paulson, T.J. Abbruscato, R.J. Mumper, and D.D. Allen In vivo and in vitro assessment of baseline blood-brain barrier parameters in the presence of novel nanoparticles Pharm. Res. 20 5 2003 705 713
18. J.M. Koziara, P.R. Lockman, D.D. Allen, and R.J. Mumper In situ blood-brain barrier transport of nanoparticles Pharm. Res. 20 11 2003 1772 1778
19. M.O. Oyewumi, and R.J. Mumper Gadolinium loaded nanoparticles engineered from microemulsion templates Drug Dev. Ind. Pharm. 28 3 2002 317 328
20. S. Nsereko, and M. Amiji Localized delivery of paclitaxel in solid tumors from biodegradable chitin microparticle formulations Biomaterials 23 2002 2723 2731
21. Y. Takasato, S.I. Rapoport, and Q.R. Smith An in situ brain perfusion technique to study cerebrovascular transport in the rat Am. J. Physiol. 247 1984 484 493
22. D.D. Allen, J. Oki, and Q.R. Smith An update in the in situ rat brain perfusion technique: simpler, faster, better Pharm. Res. 14 Suppl. 1997 337
23. Q.R. Smith Brain perfusion systems for studies of drug uptake and metabolism in the central nervous system Pharm. Biotechnol. 8 1996 285 307
24. D.D. Allen, and Q.R. Smith Characterization of the blood-brain barrier choline transporter using the in situ rat brain perfusion technique J. Neurochem. 76 2001 1 11
25. P.R. Lockman, R.J. Mumper, and D.D. Allen Evaluation of blood-brain barrier thiamine efflux using the in situ rat brain perfusion method J. Neurochem. 86 2003 637 644
26. D.J. Begley In situ brain perfusion W.M. Pardridge Introduction to the Blood-Brain Barrier 1998 Cambridge Univ. Press UK 32 40
27. P.R. Lockman, M.O. Oyewumi, J.M. Koziara, K.E. Roder, R.J. Mumper, and D.D. Allen Brain uptake of thiamine-coated nanoparticles J. Control. Release 93 2003 271 282
28. P.L. Kornblith, and M. Walker Chemotherapy for malignant gliomas J. Neurosurg. 68 1988 1 17
29. L.M. DeAngelis Brain tumors N. Engl. J. Med. 344 2001 114 123
30. Z.R. Cohen, D. Suki, J.S. Weinberg, E. Marmor, F.F. Lang, D.M. Gershenson, and R. Sawaya Brain metastases in patients with ovarian carcinoma: prognostic factors and outcome J. Neuro-oncol. 66 2004 313 325
31. F.J. Lagerwaard, P.C. Levendag, P.J. Nowak, and W.M. Eijkenboom Identification of prognostic factors in patients with brain metastases: a review of 1292 patients Int. J. Radiat. Oncol. Biol. Phys. 43 1999 795 803
32. M.J. van den Bent The role of chemotherapy in brain metastases Eur. J. Cancer 39 2003 2114 2120
33. A. Muacevic, F.W. Kreth, J.C. Tonn, and B. Wowra Stereotactic radiosurgery for multiple brain metastases from breast carcinoma Cancer 100 2004 1705 1710
34. D.J. Steward A critique of the role of the blood-brain barrier in the chemotherapy of human brain tumors J. Neuro-oncol. 20 1994 121 139
35. M.G. Donelli, M. Zucchetti, and M. D'Incalci Do cancer agents reach the tumor target in the human brain? Cancer Chemother. Pharmacol. 30 1992 251 260
36. L. Wu, A.M. Smythe, S.F. Stinson, L.A. Mullendore, A. Monks, and D.A. Scudiero Multidrug-resistant phenotype of disease-oriented panels of human tumor cell lines used for anticancer drug screening Cancer Res. 52 1992 3029 3034
37. U. Stein, K. Jurchott, W. Walther, S. Bermann, P.M. Schlag, and H.D. Royer Hypothermia-induced nuclear translocation of transcription factor YB-1 leads to enhanced expression of multidrug resistance-related ABS transporters J. Biol. Chem. 276 30 2001 28562 28569
38. D.M. Woodcock, M.E. Linsenmeyer, G. Chojnowski, A.B. Kriegler, V. Nink, L.K. Webster, and W.H. Sawyer Reversal of multidrug resistance by surfactants Br. J. Cancer 66 1992 62 68
39. Y. Lo Relationship between the hydrophilic-lipophilic balance values of pharmaceutical excipients and their multidrug resistance modulating effect in Caco-2 cells and rat intestines J. Control. Release 90 2003 37 48